Cardiovascular Effects of Very Low Nicotine Content Cigarettes
NCT05707871 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 49
Last updated 2025-10-03
Summary
The study is measuring Cardiovascular effects of very low nicotine content cigarettes on daily and non-daily smokers
Conditions
- Tobacco Use
Interventions
- DRUG
-
SPECTRUM cigarettes
SPECTRUM cigarettes have varying amount of nicotine content
- OTHER
-
usual brand of Cigarettes
Usual Brand of Cigarettes
Sponsors & Collaborators
-
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Eric C Donny, PhD · Wake Forest University Health Sciences
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-04-04
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine
NCT00777569 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
NCT05658471 ·Status: COMPLETED ·Phase: NA
-
Examining the Generality of Laboratory-based Findings and Their Moderators in the ITC Study
NCT06456671 ·Status: COMPLETED ·Phase: NA
-
Evaluating New Nicotine Standards for Cigarettes - Project 3
NCT03194256 ·Status: COMPLETED ·Phase: NA
-
Reduced Nicotine Cigarette Purchasing Decisions
NCT04999644 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Nicotine Replacement Therapy and Cardiovascular Disease
NCT02195739 ·Status: UNKNOWN
-
Acute Effects of Oral Nicotine Pouches
NCT07128329 ·Status: RECRUITING ·Phase: PHASE1
-
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
NCT03272685 ·Status: COMPLETED ·Phase: PHASE3
-
Little Cigar Oxidants
NCT06310187 ·Status: RECRUITING ·Phase: NA
-
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
NCT04231539 ·Status: COMPLETED ·Phase: NA
-
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
NCT02870218 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Electronic Cigarettes on Nicotine Concentrations
NCT01775787 ·Status: COMPLETED ·Phase: NA
-
Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge
NCT01075659 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Smoking Abstinence
NCT01035632 ·Status: COMPLETED
-
Adverse Airway Effects From Tobacco and E-Cigarettes
NCT03251053 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetic Study Comparing Nicotine Delivery From E-cigarettes and a Conventional Cigarette in Healthy Subjects
NCT02474849 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Nicotine Pharmacokinetics and Smoking Behaviour Study Examining Cigarette Ingredients
NCT03272295 ·Status: COMPLETED ·Phase: NA
-
A Randomised, Cross-Over, Nicotine Pharmacokinetic and Pharmacodynamic Study of Heated Tobacco Products Compared to Combustible Cigarettes
NCT05459857 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products.
NCT03692078 ·Status: COMPLETED ·Phase: NA
-
Effects of Nicotine Pouch Characteristics on Perceptions and Behavior
NCT06597435 ·Status: RECRUITING ·Phase: NA
-
Addictive Threshold of Nicotine
NCT06096714 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes
NCT03105804 ·Status: COMPLETED ·Phase: NA
-
Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.
NCT01227720 ·Status: COMPLETED ·Phase: NA
-
The Effect of Cytisine Treatment for Smoking Cessation on Cardiovascular Function in Adult Smokers
NCT06885970 ·Status: RECRUITING
-
E-cigarettes and Blood Vessel Function
NCT02740595 ·Status: COMPLETED ·Phase: NA